1. Home
  2. ASPN vs EVO Comparison

ASPN vs EVO Comparison

Compare ASPN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

N/A

Current Price

$5.10

Market Cap

363.8M

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.95

Market Cap

778.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
EVO
Founded
2001
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
363.8M
778.3M
IPO Year
2011
2007

Fundamental Metrics

Financial Performance
Metric
ASPN
EVO
Price
$5.10
$1.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$4.25
$7.00
AVG Volume (30 Days)
1.7M
43.3K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$271,103,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$50.03
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$1.89
52 Week High
$9.35
$4.27

Technical Indicators

Market Signals
Indicator
ASPN
EVO
Relative Strength Index (RSI) 44.39 40.65
Support Level $5.11 $1.90
Resistance Level $5.77 $2.20
Average True Range (ATR) 0.48 0.05
MACD -0.04 0.02
Stochastic Oscillator 18.01 20.97

Price Performance

Historical Comparison
ASPN
EVO

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: